Abbott Laboratories Pakistan : Transmission of Annual Report for the Year Ended December 31, 2021
March 24, 2022 at 05:38 am EDT
Share
Empowering
Health
A N N U A L R E P O R T 2 0 2 1
INTRODUCTION
At Abbott, our leadership position comes from the power of vision, innovation, and commitment - continuous threads that run through our history, not just globally, but here in Pakistan throughout our 73 years' presence. Today this power of leadership continues to drive our focus to deliver more and better outcomes for people across the nation and thereby address some of the most pressing health challenges here in Pakistan.
CONTENTS
Corporate Information
Senior Management Team
CEO's Message
Corporate Structure
Ownership and Operating Structure
Composition of Local versus Imported Materials
Our Vision and Our Mission
Our Values
Key Performance Indicators
Abbott Today
Awards and Recognitions
Shaping the Future of Healthcare
04
05
06
08
Product Launches
17
09
Abbott Leading
20
Value Chain
22
09
Business Model - Integrated
10
Reporting Framework
24
11
History Timeline
26
12
Geographical Presence
28
13
Abbott Pakistan at a Glance
30
14
Established Pharmaceuticals
32
16
Nutrition
34
Diagnostics
36
Diabetes Care
38
Objectives and Strategies
40
Analysis of Non-Financial
Performance against
Indicators
42
Risk Management at Abbott
45
Key Risks and Opportunities
Report
46
Significant Factors affecting the
External Environment and the
Organisation's Response
48
Corporate Social Responsibility
50
Environment, Health and Safety
52
Social and Environmental
Responsibility Policy
54
Human Resources
56
Quality Assurance
60
Ethics and Compliance
62
Corporate Governance
64
Supporting Our Communities
72
Our Citizenship and Sustainability
Priorities
76
Integrated Reporting Framework
82
Unreserved Statement of
Compliance to International
Financial Reporting Standards
83
Audit Committee Report
84
Directors' Profile
86
Brief Terms of Reference of
Board Committees
88
Board Committees Attendance
89
Forward Looking Statement
90
Review Report by the Chairman
92
Review Report by the Chairman
(Urdu)
93
Directors' Report
94
Directors' Report (Urdu)
105
2021 Financial Report
106
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Abbott Laboratories Pakistan Ltd. published this content on 24 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 March 2022 09:37:00 UTC.
Abbott Laboratories Pakistan Limited is engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products. The Company operates through four segments: Pharmaceutical, Nutritional, Diagnostic, and Others. It offers treatment options for a number of areas, including the digestive system, heart health, womenâs health, respiratory illness, central nervous system/pain and influenza vaccines. Its nutritional brands include Similac, PediaSure, Pedialyte, Ensure, and Glucerna. It offers tests and diagnostic tools, medical diagnostic instruments, automation and informatics solutions for hospitals, reference labs, blood centers, emergency departments, physician offices and clinics. The Companyâs easy-to-use test strips require only tiny blood samples while its meters provide results and reports.
ABBOTT LABORATORIES (PAKISTAN) LIMITED 
